跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 18 条关于
“METTL14”
全部
18
临床试验
7
药物
5
机构
0
资讯
6
11个月前
METTL14 Emerges as Key Regulator of Tumor Immunity and Immunotherapy Response
去年
FDA Approves FoundationOne Liquid CDx as Companion Diagnostic for Tepotinib in METex14-Skipping NSCLC
上个月
Targeting the m6A Writer METTL3 Shows Neuroprotective Potential in Neuroinflammation
去年
STC-15, a Novel METTL3 Inhibitor, Shows Clinical Promise Across Multiple Tumor Types in Phase 1 Trial
2年前
Targeting Post-Transcriptional RNA-Modification with a First-to-Clinic METTL3 Inhibitor: STC15
5个月前
Storm Therapeutics Secures $56M Series C to Advance First-in-Class METTL3 Inhibitor STC-15 in Phase II Sarcoma Trial